2025 Predictions: How Specialty Pharmacies Will Drive Patient Education Amid Medicare Changes
Specialty pharmacies and patient education: how the Medicare Prescription Payment Plan elevates their role in 2025, part three of Remy's predictions series.
Remy Healthcare Team
4 min read · December 24, 2024 · Updated August 11, 2026

Editor's note: This article was published in December 2024 and reflects our outlook at that time. We have kept the original analysis intact for the record. For where 340B policy stands now, see The 340B Rebate Model: What Covered Entities Need to Know.
Across Prediction 1 and Prediction 2, we explored how the medical landscape is evolving and what these changes mean for healthcare providers, TPAs, and specialty pharmacies. Now it's time to dive into our final - and perhaps most transformative - prediction.
The Medicare Prescription Payment Plan took effect on January 1, 2025, and one critical question remains: How can healthcare providers help patients understand and adapt to this system?
Our prediction? Specialty pharmacies will take center stage as educators and advocates, bridging the gap between complex healthcare policies and the patients they're designed to serve. From explaining new payment structures to supporting treatment adherence, the role of specialty pharmacies will be more essential than ever.
Ready to discover how this shift could impact your organization - and the steps you can take? Let's unpack the final piece of the puzzle.
Prediction 3: Specialty Pharmacies Will Play a Crucial Role in Patient Education Under the Medicare Prescription Payment Plan
Now that the Medicare Prescription Payment Plan is live, the role of specialty pharmacies in patient education is more pivotal than ever.
Specialty pharmacies that manage complex medication therapies need to step up so that patients understand how their medications work and how the new payment structure affects them.
This is exactly where accurate education matters, because the program is widely misunderstood. The Medicare Prescription Payment Plan does not reduce or cap what a beneficiary owes. It changes when they pay it. Part D enrollees who opt in stop paying cost sharing at the pharmacy counter and instead repay their plan in capped monthly installments spread across the plan year. The total is the same - the timing is smoothed, which can help with a large up-front cost early in the year but does not lower the bill.
The annual cap on Part D out-of-pocket spending is a separate Inflation Reduction Act provision. Conflating the two is one of the easiest ways to set a patient's expectations incorrectly, which makes pharmacies a key touchpoint for explaining the difference, answering questions, and guiding patients through their medication access journey.
For healthcare centers and FQHCs, this shift means they must strengthen partnerships with specialty pharmacies. Ensuring patients receive accurate, timely information can help avoid medication errors and improve treatment outcomes. As a result, FQHCs will likely need to allocate resources to collaborate closely with specialty pharmacies to support effective patient education.
Moreover, as specialty pharmacies bridge the gap between Medicare payment changes and patient care, FQHCs can reduce administrative burdens while focusing on delivering high-quality care.
Closer coordination between education and treatment can help vulnerable populations keep receiving the comprehensive support they need in a shifting healthcare landscape, and it is an important part of the industry we expect to see grow and evolve.
Adapting to Change: Your Path Forward
As we've explored across this series, the 340B and specialty pharmacy landscape is in a period of significant change. From navigating regulatory updates to forging stronger partnerships and empowering patient education, the key to success will lie in preparation and adaptability.
The road ahead may seem complex, but with the right strategies and support, your organization can thrive in this evolving environment. At Remy Healthcare, we specialize in turning challenges into opportunities, helping healthcare providers like you optimize their 340B programs and deliver better outcomes for patients.
Contact Remy Healthcare today to start building your roadmap. Our team is ready to work through the process with you and support the compliance and operational decisions your organization owns.
Thank you for joining us for this series - and remember, the future of healthcare starts with the decisions you make today. Let's navigate it together!

Written by
Remy Healthcare Team
340B & FQHC Specialists
The Remy team advises FQHCs and 340B covered entities on program management, infusion operations, and revenue optimization.


